Paige Kilian of Inovalon Addresses the Challenges of Risk Adjustment and how Solutions Can Be Found Through Data and Analytics

The drugs must have full “traditional” FDA approval and patients need to be enrolled in a registry that collects post-approval data efficacy and safety when the drugs are used in clinical practice.

This month’s episode of the "What's On Your Mind" podcast series features Eric Hunter, president and CEO of CareOregon. MHE Managing Editor Peter Wehrwein, Editor Briana Contreras and Hunter discuss Medicaid redetermination and merger of CareOregon and the California-based insurer, SCAN Group.

Understanding whether the prevention of RSV infection during infancy can reduce the risk of childhood asthma is key to designing successful and preventive strategies, preventing long-term childhood respiratory morbidity, and outlining healthcare policy measures.

This month's episode of Tuning In to the C-Suite features Erica Jain, CEO & co-founder of digital health company, Healthie. In this discussion, Jain shared some of the challenges or things to avoid when creating a digital health startup, based on her journey with starting Healthie in 2016. She also addressed some best practices and tools that can help those working toward a digital health startup.

The head of a gastroenterologist group criticizes the company for having a "slapdash approach."

Vanderbilt’s Stacie Dusetzina and colleagues explain how the ‘copay adjustment’ programs work in this week’s JAMA Internal Medicine and also shed light on third strategy used by insurers and pharmaceutical benefit managers, the alternative payment program.